Successful vaccination with tetanus and diphtheria and acelluar pertussis vaccine after adverse reaction to diphtheria and tetanus toxoids and acellular pertussis vaccine or diphtheria and tetanus vaccine in pediatric patients.
作者信息
Campbell Neha Sirohi, Kalman Denise Diprimio
机构信息
Division of Allergy & Immunology, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
Division of Allergy & Immunology, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware.
出版信息
Ann Allergy Asthma Immunol. 2019 Oct;123(4):409-411. doi: 10.1016/j.anai.2019.06.006. Epub 2019 Jun 20.
PMID:31228630
Abstract
摘要
相似文献
1
Successful vaccination with tetanus and diphtheria and acelluar pertussis vaccine after adverse reaction to diphtheria and tetanus toxoids and acellular pertussis vaccine or diphtheria and tetanus vaccine in pediatric patients.儿科患者在对白喉破伤风类毒素和无细胞百日咳疫苗或白喉破伤风疫苗出现不良反应后成功接种破伤风、白喉和无细胞百日咳疫苗。
Ann Allergy Asthma Immunol. 2019 Oct;123(4):409-411. doi: 10.1016/j.anai.2019.06.006. Epub 2019 Jun 20.
2
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.在韩国，一项比较联合使用无细胞百白破、灭活脊髓灰质炎（DTaP-IPV）疫苗与分别单独使用百白破（DTaP）和脊髓灰质炎（IPV）疫苗的免疫原性和安全性的随机对照研究：在婴儿中进行的研究。
Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.
3
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.联合低抗原含量白喉-破伤风-无细胞百日咳和脊髓灰质炎疫苗（dTpa-IPV）用于成人加强免疫接种。
Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013.
4
Further investigations of the IgE response to tetanus and diphtheria following covaccination with acellular rather than cellular Bordetella pertussis.进一步研究细胞性而非细胞性百日咳博德特氏菌联合接种后破伤风和白喉的 IgE 反应。
Pediatr Allergy Immunol. 2019 Dec;30(8):841-847. doi: 10.1111/pai.13113.
5
Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.无细胞百日咳疫苗：18至24月龄儿童中，无细胞百日咳疫苗与全细胞百日咳疫苗联合白喉和破伤风类毒素作为加强疫苗的免疫原性和安全性比较
Pediatr Infect Dis J. 1987 Apr;6(4):352-63. doi: 10.1097/00006454-198704000-00004.
6
Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants.婴儿用白喉破伤风类毒素和双组分无细胞百日咳疫苗与白喉破伤风类毒素和全细胞百日咳疫苗的比较
Am J Dis Child. 1993 Mar;147(3):295-9. doi: 10.1001/archpedi.1993.02160270057018.
7
Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.青少年用无细胞百日咳疫苗加强针与白喉和破伤风类毒素加强针联合使用：在不同的5剂次白百破疫苗/全细胞百日咳疫苗接种程序后进行安全性和免疫原性评估。
Clin Pediatr (Phila). 2006 Sep;45(7):613-20. doi: 10.1177/0009922806289593.
8
9
10
[ON COMBINED IMMUNIZATION BY PERTUSSIS-DIPHTHERIA-TETANUS AND SMALLPOX VACCINES].[关于百日咳-白喉-破伤风联合免疫与天花疫苗接种]
Zh Mikrobiol Epidemiol Immunobiol. 1963 Sep;40:30-6.
Zotero 插件